Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2021-09-01
2023-02-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: The 42 patients who participated in the study were randomly divided into 2 groups \[group 1: SE (n= 21), group 2: SE + CSE (n= 21)\]. The first 8 weeks of the post-discharge follow-up were performed by videoconference-based TR under the supervision of a physiotherapist and the last 4 weeks by telephone-based TR. Functional level was assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), pain intensity by Visual Analog Scale (VAS), affected knee range of motion (ROM) by Copenhagen Knee Range of Motion Scale (CKRS), quality of life by Short Form-12 (SF-12) and World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF), lower extremity muscle strength by 30-seconds Chair-Stand Test and locomotor performance by Stair Climb Test. Assessments were performed with TR preoperatively and at the first, second and third post-op months.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the follow-up period, only the interventions included in the standard exercise (SE) program were applied to the SE group, while interventions included in both the SE and core stability exercise (CSE) program were applied to the SE + CSE group. In addition to the TR sessions, each patient performed the interventions belonging to the group they were included in as a home program (HP), 3 sessions per day for the first 8 weeks of the follow-up period. Patient follow-up, which started from the 1st week after discharge, continued for 12 weeks. The content of the follow-up process was planned to include information, assessment, and PTR interventions. The first 8 weeks of the follow-up period consisted of PTR sessions performed with video-conference-based TR method under the supervision of a physiotherapist and HP, while the last 4 weeks consisted of the follow-up of the walking program performed with telephone-based TR method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: SE Group
SE: standard exercises During the follow-up period, only the interventions included in the standard exercise program were applied to the SE Group.
standard exercises
Standard exercises for TKA patients.
Group 2: SE + CSE Group
CSE: core stability exercises During the follow-up period interventions included in both the standard and core stability program were applied to the SE + CSE group.
standard exercises
Standard exercises for TKA patients.
core stability exercises
Core stability exercises for TKA patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard exercises
Standard exercises for TKA patients.
core stability exercises
Core stability exercises for TKA patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing primary unilateral TKA
* To be able to understand, speak and write Turkish,
* be able to understand verbal and written information, have internet access
* be able to use a video conferencing program
Exclusion Criteria
* To have undergone any major surgery on the lower extremities
* Comorbid diseases such as rheumatoid arthritis, cancer, etc,
* Neurological disease causing functional disability
* Have a diagnosed psychiatric disorder
* Being addicted to alcohol or drugs
* Have a hearing or visual impairment that cannot be corrected with hearing aids or glasses,
* Being morbidly obese (BMI\>40 kg/m2)
* be unable to participate in a twelve-week rehabilitation program
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pamukkale University
OTHER
Burdur Mehmet Akif Ersoy University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akın Süzer
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akın Süzer, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Burdur Mehmet Akif Ersoy University
Nihal Büker, PT, PhD
Role: STUDY_DIRECTOR
Pamukkale University
Harun R Güngör, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Pamukkale University
Nusret Ök, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Pamukkale University
Raziye Şavkın, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Pamukkale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Burdur Mehmet Akif Ersoy University
Burdur, , Turkey (Türkiye)
Pamukkale University
Denizli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ErsoyU.E-60116787-020-90137
Identifier Type: -
Identifier Source: org_study_id